Insider trade

Director received an award of 1,766.09 PFE derivative securities

Traded Sep 30, 2025 · Filed Oct 2, 2025

PfizerPFE

1,766.09
Derivative units · @ $25.48

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Sep 30, 2025
Reporting period: Not applicable
Filed with the SEC: Oct 2, 2025

DirectorGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001225208-25-008326
Filed / recorded

Oct 2, 2025, 8:56 PM UTC

Added to OQRO

Oct 1, 2026, 11:17 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

PFIZER INC

Issuer CIK

78003

Ticker

PFE

Reporting person

James C Smith

Relationship

Director

Security

Phantom Stock Units

Table

Derivative (Table II)

Transaction date

Sep 30, 2025

Transaction code

A

Shares / units

1,766.091

Price per share

$25.48

Acquired / disposed

Acquired (A)

Shares owned after

161,563.412

Ownership form

Direct

Amendment

No

Footnotes from the filing

Each unit represents one phantom share of common stock.
These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.